Curing cancer with Cannabidiol?
- CANNABIS OIL, NEWS
- April 24, 2013
For the last 18 days, Phoenix, AZ has hit 110 or more degrees. And because of the extended period, the night cool down has not materialized with it barely dropping to 90 degrees. While there have been other places (Death Valley, CA and Casa Grande, AZ) who have topped had higher, this is the first big
READ MORENow that recreational pot has been legalized in 23 states, the cannabis industry is borrowing a marketing trick from the booze industry: “hangover holidays.” Or, in this case, “hashish holidays.” Most people are aware that marijuana buffs celebrate each April 20, or “420.” And the day before Thanksgiving ― aka “Weed Wednesday” ― is reportedly a big sales opportunity for dispensaries. But Monday, July
READ MOREA British cannabis products maker known for selling its CBD oils on eBay, Amazon and in UK chemist Boots wants to make its products more accessible to Australians and plans to list on the ASX. Dragonfly Biosciences is hoping to hit the local sharemarket at the start of August and has launched an initial public
READ MOREWhile the benefits and risks of cannabidiol, or CBD, are well known and include upsides such as pain relief and inflammation reduction and potential downsides like upset stomach or irritability, some people aren’t aware of the different forms the chemical compound is available in. It can be taken as an ingestible edible via foods, pills, beverages and gummies, or absorbed through the skin by way of
READ MORE“This gives an opportunity for virtually every community to have access.” By Dave Williams, Capitol Beat Georgians eligible to treat their chronic illnesses with cannabis oil soon will have a lot more choices of places to get the medicine. The state Board of Pharmacy has released a set of regulations that will allow Georgia’s independent
READ MOREAustralian researchers have published the first robust clinical study proving that medicinal cannabis effectively treats the debilitating effects of Tourette syndrome. The findings—which show a statistically and clinically significant reduction in motor and vocal tics in just six weeks—are published in the journal NEJM Evidence. The clinical trial was led by neuropsychiatrist Dr. Philip Mosley, a Research Fellow
READ MORE